REGN DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important March 10 Deadline in Securities Class Action - REGN
Portfolio Pulse from
Rosen Law Firm is urging investors of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) who purchased securities between November 2, 2023, and October 30, 2024, to secure counsel before the March 10, 2025, deadline in a securities class action.
March 05, 2025 | 12:45 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Rosen Law Firm is encouraging Regeneron investors to join a securities class action by March 10, 2025, if they purchased shares between Nov 2, 2023, and Oct 30, 2024.
The class action lawsuit could lead to financial liabilities for Regeneron, potentially impacting its stock price negatively in the short term. The deadline for lead plaintiff is March 10, 2025.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100